Vivos Therapeutics to acquire SOD Sciences stake and test interest
Vivos Therapeutics agreed to acquire a minority stake in SOD Sciences and a 50% interest in its proprietary pseudohypoxia test.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.